Cas no 62488-57-7 (1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl-)
1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl- Chemical and Physical Properties
Names and Identifiers
-
- 1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl-
- 5,6-Dihydro-5-azacytidine
- 5,6 dihydro-5-azacytidine
- Ccris 6743
- DHAC
- Dihydro-5-azacytidine
- NSC 264-880
- NSC 26480
- NSC 265483
- { "\"0\"": "DHAC" }
- { "\"1\"": " Dihydro-5-azacytidine" }
- { "\"2\"": " NSC 264-880" }
- { "\"3\"": " NSC 26480" }
- { "\"4\"": " NSC 265483" }
-
- MDL: MFCD00800370
- Inchi: 1S/C8H14N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h3-6,13-15H,1-2H2,(H3,9,10,11,16)
- InChI Key: LJIRBXZDQGQUOO-UHFFFAOYSA-N
- SMILES: O1C(CO)C(C(C1N1C(NC(N)=NC1)=O)O)O
Computed Properties
- Exact Mass: 246.09652
- Monoisotopic Mass: 246.096
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 17
- Rotatable Bond Count: 2
- Complexity: 349
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 141A^2
- XLogP3: -3
Experimental Properties
- Density: 2.10±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: 216-221 °C (decomposition)
- Boiling Point: 529.1°C at 760 mmHg
- Flash Point: 273.8°C
- Refractive Index: 1.823
- Solubility: Slightly soluble (7.4 g/l) (25 o C),
- PSA: 140.64
- LogP: -2.87460
1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| DC Chemicals | DC9997-100 mg |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 100mg |
$1100.0 | 2022-03-01 | |
| DC Chemicals | DC9997-250 mg |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 250mg |
$1800.0 | 2022-03-01 | |
| DC Chemicals | DC9997-1 g |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 1g |
$3500.0 | 2022-03-01 | |
| eNovation Chemicals LLC | Y0990754-1g |
5,6-dihydro-1H-pyrrolo[3,2-c]pyridinecytidine |
62488-57-7 | 95% | 1g |
$2750 | 2025-02-25 | |
| eNovation Chemicals LLC | Y0990754-1g |
5,6-dihydro-1H-pyrrolo[3,2-c]pyridinecytidine |
62488-57-7 | 95% | 1g |
$2750 | 2025-02-24 | |
| eNovation Chemicals LLC | Y0990754-1g |
5,6-dihydro-1H-pyrrolo[3,2-c]pyridinecytidine |
62488-57-7 | 95% | 1g |
$2750 | 2024-08-02 | |
| DC Chemicals | DC9997-100mg |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 100mg |
$1100.0 | 2023-09-15 | |
| DC Chemicals | DC9997-250mg |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 250mg |
$1800.0 | 2023-09-15 | |
| DC Chemicals | DC9997-1g |
5,6-Dihydro-5-azacytidine |
62488-57-7 | >98% | 1g |
$3500.0 | 2023-09-15 |
1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl- Suppliers
1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl- Related Literature
-
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
Additional information on 1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl-
1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl: A Comprehensive Overview
The compound with CAS No. 62488-57-7, known as 1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The triazinone core of the molecule is a key feature that contributes to its versatility in various chemical reactions and biological interactions.
Recent studies have highlighted the importance of ribofuranosyl derivatives in nucleic acid chemistry and antiviral therapy. The b-D-ribofuranosyl group in this compound suggests its potential role in RNA-related processes. Researchers have explored the synthesis of similar compounds to understand their interaction with RNA polymerases and their potential as antiviral agents.
The 4-amino substitution on the triazinone ring adds another layer of functionality to this compound. This amino group can participate in various chemical transformations, such as amidation or alkylation, making it a valuable intermediate in organic synthesis. Furthermore, the 3,6-dihydro configuration indicates a degree of unsaturation that may influence the compound's stability and reactivity.
From a structural standpoint, the molecule exhibits a balance between aromaticity and flexibility. The triazinone ring provides aromatic stability, while the ribofuranosyl group introduces flexibility, enabling the molecule to adopt various conformations. This balance is crucial for its interactions with biological targets and its potential use in medicinal chemistry.
Recent advancements in computational chemistry have allowed researchers to model the behavior of 1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl in different environments. These studies have provided insights into its electronic properties and how they might influence its reactivity and selectivity in biochemical systems.
In terms of synthesis, this compound can be prepared through a variety of methods. One common approach involves the condensation of appropriate amino sugars with triazinone precursors under controlled conditions. The reaction conditions are critical to ensure the desired stereochemistry and regioselectivity of the product.
The biological evaluation of this compound has revealed interesting properties that warrant further investigation. For instance, studies have shown that it exhibits moderate activity against certain enzymes involved in viral replication. This finding has sparked interest in exploring its potential as an antiviral agent.
Moreover, the triazinone moiety has been implicated in various pharmacological activities. Its ability to act as a scaffold for drug design has led to its incorporation into numerous lead compounds for therapeutic applications.
In conclusion, 1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl is a versatile compound with promising applications in organic synthesis and medicinal chemistry. Its unique structure and functional groups make it an attractive candidate for further research and development.
62488-57-7 (1,3,5-Triazin-2(1H)-one,4-amino-3,6-dihydro-1-b-D-ribofuranosyl-) Related Products
- 320-67-2(5-Azacytidine)
- 65886-71-7(Fazarabine)
- 62402-31-7(5,6-dihydro-5-azacytidine Hydrochloride)
- 27826-77-3(1,3,5-Triazin-2(1H)-one,4-(dimethylamino)-1-b-D-ribofuranosyl-)
- 65886-72-8(6-amino-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,4-dihydro-1,3,5-triazin-2-one;hydrochloride)
- 65370-91-4(6-amino-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-1,3,5-triazine-2,4-dione)
- 27826-76-2(1,3,5-Triazin-2(1H)-one,4-(methylamino)-1-b-D-ribofuranosyl-)
- 1476-82-0(5-Azauridine)
- 71084-42-9(6-amino-3-[3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-yl]-1,4-dihydro-1,3,5-triazin-2-one;hydrochloride)
- 65126-88-7(N-[(N'-formylcarbamimidoyl)carbamoyl]pentofuranosylamine)